title: FDA needs a more "nuanced" approach to advisers' conflicts of interest, researchers say.
authors.affiliation: Montreal.
authors.forename: Owen
authors.initials: O
authors.lastname: Dyer
mesh_terms: D026683:Advisory Committees / Q000191:economics / Q000941:ethics*; D016265:Conflict of Interest; D004345:Drug Industry / Q000191:economics; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration